EVH vs TBRG

EVH exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a significant YoY revenue decline of 27.50%. While the stock trades at a low Price-to-Book (0.84) and Price-to-Sales (0.19) ratio, these metrics likely represent a value trap given the negative profit margins (-28.49%) and high debt-to-equity ratio (2.38). Despite a 'Strong Buy' analyst consensus and a target price of $5.18, the deterministic data and long-term price performance (-85.2% over 5 years) suggest a high-risk profile with failing operational momentum.

TBRG exhibits a strong operational turnaround indicated by a Piotroski F-Score of 7/9, yet it faces a severe valuation disconnect. While the current price of $23.18 trades at a massive premium to the Graham Number ($8.94) and Intrinsic Value ($2.03), the Forward P/E of 7.92 and PEG of 0.28 suggest the market is pricing in an aggressive earnings explosion. The company's pivot to Revenue Cycle Management (RCM) is yielding significant EPS surprises, but thin profit margins and market saturation in the small-hospital segment remain critical headwinds.